We have no clinical data on insulin sensitivity; since liraglutide may play a role in reducing insulin resistance and endothelial dysfunction [47] the metabolic changes between groups may be explained by changes in insulin sensitivity evoked by liraglutide. Here, INS is linked to endothelial dysfunction.